These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 9290051
1. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity]. Pavlov AIu, Olsuf'eva EN, Miroshnikova OV, Reznikova MI, Lazhko EI, Malabarba A, Ciabatti R, Preobrazhenskaia MN. Bioorg Khim; 1997 May; 23(5):410-21. PubMed ID: 9290051 [Abstract] [Full Text] [Related]
2. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Preobrazhenskaya MN. J Med Chem; 2003 Mar 27; 46(7):1204-9. PubMed ID: 12646030 [Abstract] [Full Text] [Related]
6. [Recent advances in the study of synthesis and activity of vancomycin derivatives]. Chen YY, Liu G. Yao Xue Xue Bao; 2007 May 27; 42(5):463-9. PubMed ID: 17703765 [Abstract] [Full Text] [Related]
7. [Glycopeptide antibiotics resistance mechanism as the basis for novel derivatives development capable to overcome resistance]. Trenin AS, Olsuf'eva EN. Bioorg Khim; 1997 Nov 27; 23(11):851-67. PubMed ID: 9518425 [Abstract] [Full Text] [Related]
11. Semisynthetic glycopeptides: chemistry, structure-activity relationships and prospects. Ciabatti R, Malabarba A. Farmaco; 1997 May 27; 52(5):313-21. PubMed ID: 9274002 [Abstract] [Full Text] [Related]
12. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. Synthesis, structural and antibacterial studies. Sztaricskai F, Batta G, Herczegh P, Balázs A, Jeko J, Roth E, Szabó PT, Kardos S, Rozgonyi F, Boda Z. J Antibiot (Tokyo); 2006 Sep 27; 59(9):564-82. PubMed ID: 17136889 [Abstract] [Full Text] [Related]
13. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria. Nakamura J, Yamashiro H, Hayashi S, Yamamoto M, Miura K, Xu S, Doi T, Maki H, Yoshida O, Arimoto H. Chemistry; 2012 Oct 01; 18(40):12681-9. PubMed ID: 22915313 [Abstract] [Full Text] [Related]
14. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. Griffin JH, Linsell MS, Nodwell MB, Chen Q, Pace JL, Quast KL, Krause KM, Farrington L, Wu TX, Higgins DL, Jenkins TE, Christensen BG, Judice JK. J Am Chem Soc; 2003 May 28; 125(21):6517-31. PubMed ID: 12785792 [Abstract] [Full Text] [Related]
16. Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal. Pavlov AY, Berdnikova TF, Olsufyeva EN, Lazhko EI, Malkova IV, Preobrazhenskaya MN, Testa RT, Petersen PJ. J Antibiot (Tokyo); 1993 Nov 28; 46(11):1731-9. PubMed ID: 8270496 [Abstract] [Full Text] [Related]
17. The biosynthesis of glycopeptide antibiotics--a model for complex, non-ribosomally synthesized, peptidic secondary metabolites. Süssmuth RD, Wohlleben W. Appl Microbiol Biotechnol; 2004 Jan 28; 63(4):344-50. PubMed ID: 14564489 [Abstract] [Full Text] [Related]
18. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE). Jia Y, Bois-Choussy M, Malabarba A, Brunati C, Zhu J. J Antibiot (Tokyo); 2006 Sep 28; 59(9):543-52. PubMed ID: 17136887 [Abstract] [Full Text] [Related]
19. Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria. He H. Appl Microbiol Biotechnol; 2005 Jun 28; 67(4):444-52. PubMed ID: 15702316 [Abstract] [Full Text] [Related]
20. Nano-sized clusters of a teicoplanin ψ-aglycon-fullerene conjugate. Synthesis, antibacterial activity and aggregation studies. Tollas S, Bereczki I, Sipos A, Rőth E, Batta G, Daróczi L, Kéki S, Ostorházi E, Rozgonyi F, Herczegh P. Eur J Med Chem; 2012 Aug 28; 54():943-8. PubMed ID: 22795664 [Abstract] [Full Text] [Related] Page: [Next] [New Search]